Related Experiment Video
Updated: Apr 29, 2026
Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
Published on: June 23, 2023
Mitochondrial dysfunction in central nervous system white matter disorders
Laia Morató1, Enrico Bertini, Daniela Verrigni
1Neurometabolic Diseases Laboratory, Bellvitge Biomedical Research Institute (IDIBELL), L'Hospitalet de Llobregat, Barcelona, Spain; Center for Biomedical Research on Rare Diseases (CIBERER), ISCIII, Spain.
Abstract:
Defects of mitochondrial respiration and function had been proposed as a major culprit in the most common neurodegenerative diseases, including prototypic diseases of central nervous system (CNS) white matter such as multiple sclerosis. The importance of mitochondria for white matter is best exemplified in a group of defects of the mitochondria oxidative metabolism called mitochondria leukoencephalopathies or encephalomyopathies. These diseases are clinically and genetically heterogeneous, given the dual control of the respiratory chain by nuclear and mitochondrial DNA, which makes the precise diagnosis and classification challenging. Our understanding of disease pathogenesis is nowadays still limited. Here, we review current knowledge on pathogenesis and genetics, outlining diagnostic clues for the various forms of mitochondria disease. In particular, we underscore the value of magnetic resonance imaging (MRI) for the differential diagnosis of specific types of mitochondrial leukoencephalopathies, such as genetic defects on SDHFA1. The use of novel technologies for gene identification, such as whole-exome sequencing studies, is expected to shed light on novel molecular etiologies, broadening prenatal diagnosis, disease understanding, and therapeutic options. Current treatments are mostly palliative, but very promising novel gene and pharmacologic therapies are emerging, which may also benefit a growing list of secondary mitochondriopathies, such as the peroxisomal disease adrenoleukodystrophy.
Insights
Mitochondrial defects are implicated in neurodegenerative diseases affecting white matter. Research highlights diagnostic tools like MRI and genetic sequencing for understanding and treating these complex conditions.
Area of Science:
- Neuroscience
- Genetics
- Biochemistry
Background:
- Mitochondrial dysfunction is a key factor in neurodegenerative diseases, particularly those affecting central nervous system (CNS) white matter like multiple sclerosis.
- Mitochondrial leukoencephalopathies, a group of disorders affecting mitochondrial oxidative metabolism, exemplify the critical role of mitochondria in white matter health.
Purpose of the Study:
- To review current knowledge on the pathogenesis and genetics of mitochondrial leukoencephalopathies.
- To outline diagnostic clues for various forms of mitochondrial diseases.
- To emphasize the utility of advanced technologies in understanding and treating these disorders.
Main Methods:
- Review of current scientific literature on mitochondrial diseases and neurodegeneration.
- Analysis of diagnostic approaches, including magnetic resonance imaging (MRI).
- Discussion of novel technologies like whole-exome sequencing for gene identification.
Main Results:
- Mitochondrial diseases are clinically and genetically heterogeneous due to dual genetic control (nuclear and mitochondrial DNA).
- Magnetic resonance imaging (MRI) is valuable for differentiating specific mitochondrial leukoencephalopathies, such as those with succinate dehydrogenase complex assembly factor 1 (SDHFA1) defects.
- Emerging technologies are expected to uncover new molecular causes and improve diagnostic capabilities.
Conclusions:
- Understanding the pathogenesis and genetics of mitochondrial leukoencephalopathies is crucial for diagnosis and treatment.
- Advanced imaging and genetic sequencing techniques offer promising avenues for identifying novel etiologies and improving patient care.
- While current treatments are largely palliative, novel gene and pharmacological therapies are under development, offering hope for both primary and secondary mitochondriopathies.
Related Concept Videos
01:28Disorders of the Nervous Tissue
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
01:24Parkinson Disease ll: Pathophysiology
01:19Multiple Sclerosis l: Introduction
01:11Alterations in Muscle Tone lll
01:23Alzheimer Disease ll: Pathophysiology
01:15Parkinson's Disease: Overview